Sample - Global mHealth (Mobile Health) Market

GLOBAL MHEALTH (MOBILE HEALTH) MARKET
Focus on Ecosystem (mHealth Devices & Services),
Therapeutics, Application/ Solution Type & Regions
– Estimation & Forecast through 2015 to 2022

BIS Research Sample Page 2
Global mHealth (Mobile Health) Market: Focus on Ecosystem (mHealth Devices & Services),
Therapeutics, Application/ Solution Type & Regions – Estimation & Forecast through 2015 to 2022
BIS Research is a leading market intelligence and technology research company. BIS Research
publishes in-depth market intelligence reports focusing on the market estimations, technology
analysis, emerging high-growth applications, deeply segmented granular country-level market
data and other important market parameters useful in the strategic decision making for senior
management. BIS Research provides multi-client reports, company profiles, databases, and
custom research services.
Copyright © 2014 BIS Research
All Rights Reserved. This document contains highly confidential information and is the sole
property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing
any or all contents of this document is strictly prohibited. Access to this information is provided
exclusively for the benefit of the people or organization concerned. It may not be accessed by,
or offered whether for sale or otherwise to any third party.

TABLE OF CONTENTS
1 REPORT SCOPE .....................................................................................................21
1.1 SCOPE OF THE STUDY ............................................................... 21
1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE .......... 21
1.1.2 BIS RESEARCH METHODOLOGY ...................................... 22
1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL
MARKET STUDY.............................................................. 24
1.1.3.1 Geographical Analysis ................................................24
1.1.3.2 Demand Side & Supply Side Analysis............................25
1.1.3.3 Data Synthesis & Bridging ..........................................25
1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH
METHODOLOGY .............................................................. 26
1.1.5 KEY DATA POINT SOURCES ............................................ 27
1.1.5.1 Data Points taken from Secondary Sources ...................27
1.1.5.2 Data Points taken from Primary Sources .......................27
1.1.6 REPORT DESCRIPTION................................................... 28
2 EXECUTIVE SUMMARY .......................................................................................32
3 MARKET OVERVIEW...........................................................................................36
3.1 INTRODUCTION ........................................................................36
3.2 MARKET DYNAMICS ..................................................................36
3.2.1 MARKET DRIVERS .......................................................... 37
3.2.1.1 Patients Involvement in personal healthcare..................39
3.2.1.2 Proliferation of Smartphones and wearable devices
into healthcare..........................................................40
3.2.1.3 Integration of wireless technologies with portable
healthcare devices.....................................................41
3.2.1.4 Introduction of connected healthcare solutions in the
mHealth market ........................................................42
3.2.1.5 Benefits of Cost effectiveness and Patients’
Convenience.............................................................43
3.2.1.6 Increase in Lifestyle Disease .......................................44
3.2.2 MARKET CHALLENGES .................................................... 45

3.2.2.1 Low rate of literacy and language barriers in low-
and middle-income countries (LMICs)...........................45
3.2.2.2 Invasion of Privacy ....................................................46
3.2.2.2.1 Security Breach Cases ......................................47
3.2.2.2.2 Potential risk of Hardware or Software failure.......48
3.2.2.2.3 Stringent Regulations and Standards ..................48
3.2.2.2.4 Lack of Awareness about the possible
applications of mHealth.....................................50
3.2.3 MARKET OPPORTUNITIES .............................................. 50
3.2.3.1 Partnership: An entry mode ........................................50
3.2.3.2 Introduction of mHealth in developing economies...........51
4 INDUSTRY DYNAMICS.........................................................................................53
4.1 MHEALTH MARKET TIMELINE.................................................... 53
4.2 VALUE CHAIN OF THE MHEALTH MARKET .................................54
4.2.1.1 Device Manufacturers.................................................55
4.2.1.2 App Developers.........................................................55
4.2.1.3 Network providers/ Mobile operators ............................56
4.2.1.4 Healthcare providers and Pharmaceuticals.....................56
4.2.1.5 Patients ...................................................................56
4.2.1.6 Consortiums, Certification, Regulations, & Standards......57
4.2.1.6.1 Introduction ....................................................57
4.2.1.6.2 Consortiums....................................................58
4.2.1.6.3 Alliance/Associations ........................................60
4.2.1.6.4 Regulatory Bodies ............................................62
4.2.1.7 Food and Drug Administration (FDA) ............................66
4.2.1.8 Medical Device Regulation Act .....................................66
4.2.1.9 Medical Mobile Application(MMA) .................................67
4.2.2 CERTIFICATION ............................................................. 67
4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS...... 69
4.2.4 BARGAINING POWER OF BUYER..................................... 70
4.2.5 BARGAINING POWER OF SUPPLIER................................ 71
4.2.6 THREAT FROM SUBSTITUTE............................................ 72
4.2.7 THREAT FROM A NEW ENTRANT ..................................... 73
4.2.8 INTENSITY OF COMPETITIVE RIVALRY........................... 74

5 GLOBAL MHEALTH MARKET ECOSYSTEM...................................................76
5.1 INTRODUCTION ........................................................................76
5.1.1 MHEALTH DEVICES......................................................... 78
5.1.2 MEDICAL DEVICES ......................................................... 82
5.1.2.1 SMBG monitor...........................................................82
5.1.2.1.1 SMBG Device Types& Uses ................................82
5.1.2.1.2 Diseases Managed by SMBG Device ....................83
5.1.2.1.3 Key players .....................................................84
5.1.2.2 Blood Pressure (BP) Monitor........................................84
5.1.2.2.1 BP Monitor Device Types & Uses.........................85
5.1.2.2.2 Diseases Managed by BP Monitor Device..............86
5.1.2.2.3 Key players .....................................................86
5.1.2.2.4 Pulse Oximeter ................................................86
5.1.2.2.5 Pulse Oximeter : Types & Uses...........................87
5.1.2.2.6 Diseases Managed by Pulse Oximeter Device........87
5.1.2.2.7 Key players .....................................................88
5.1.2.3 Cardiac Monitors .......................................................88
5.1.2.3.1 Diseases Managed by Cardiac Monitors ...............88
5.1.2.3.2 Disease Management Devices Types ...................88
5.1.2.3.3 Cardiac Monitor Uses ........................................89
5.1.2.4 Key players ..............................................................89
5.1.2.5 Other medical devices ................................................89
5.1.2.5.1 Health and Fitness Devices ................................89
5.1.2.5.2 Hand Worn Products.........................................91
5.1.2.5.2.1 Smart Watch.................................................... 92
5.1.2.5.2.2 Wrist Wear....................................................... 92
5.1.2.5.3 Key players .....................................................93
5.1.2.5.4 Head Worn Products .........................................93
5.1.2.5.4.1 AR/VR HMD/HUD .............................................. 95
5.1.2.5.4.2 Others............................................................. 95
5.1.2.5.4.3 Body worn products .......................................... 96
5.1.2.5.4.4 Smart Textile ................................................... 96
5.1.2.5.4.5 Wearable Patch................................................. 97
5.1.2.5.4.6 Others............................................................. 98
5.1.2.5.5 Non-Clinical applications .................................100

5.1.2.5.6 Clinical Application .........................................102
5.1.2.6 Others Devices........................................................ 105
5.1.2.6.1 Mobile telemedicine/tele-care devices ............... 105
5.1.2.6.2 Home care devices .........................................105
5.1.2.6.2.1 Vessyl ........................................................... 105
5.1.2.6.2.2 TAO .............................................................. 105
5.1.2.6.2.3 CubeSensors .................................................. 105
5.1.2.6.2.4 Kolibree......................................................... 106
5.1.2.6.2.5 TellSpec......................................................... 106
5.1.2.6.2.6 Kinsa............................................................. 106
5.1.2.6.2.7 Beddit ........................................................... 106
5.1.2.6.2.8 Wello iPhone Case........................................... 106
5.1.2.6.3 Key Participants.............................................106
5.1.2.7 mHealth Services .................................................... 106
5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION ......... 110
5.1.3.1 Software ................................................................ 110
5.1.3.2 Big data .................................................................113
5.1.3.3 Key Market Trends, Developments and Participants ......115
5.1.3.3.1 Market Trends and Market Developments ..........115
5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS.......... 116
5.1.4.1 Benefits of network & Services ..................................117
5.1.5 HEALTHCARE AND PHARMACEUTICALS ........................ 120
5.1.5.1 Healthcare providers................................................ 120
5.1.5.2 Pharmaceuticals ...................................................... 121
5.1.5.2.1 Key Market Trends, Developments and
Participants ................................................... 121
5.1.5.2.1.1 Market Trends and Market Developments .......... 122
5.1.5.2.1.2 Key Participants.............................................. 123
6 GLOBAL MHEALTHMARKET – THERAPEUTICS .......................................124
6.1 INTRODUCTION ......................................................................124
6.1.1 GLOBAL MARKET STATISTICS....................................... 125

6.1.1.1 Cardiovascular Diseases ...........................................126
6.1.2 DEVICES ...................................................................... 128
6.1.3 APPS............................................................................ 129
6.1.4 KEY PLAYERS ............................................................... 132
6.2 DIABETES ............................................................................... 132
6.2.1 DEVICES ...................................................................... 135
6.2.2 APPS............................................................................ 135
6.2.3 KEY PLAYERS ............................................................... 137
6.3 RESPIRATORY.........................................................................137
6.3.1 DEVICES ...................................................................... 140
6.3.2 APPS............................................................................ 140
6.3.3 KEY PLAYERS ............................................................... 140
6.4 MENTAL AND NEUROLOGICAL DISORDERS ............................. 141
6.4.1 DEVICES ...................................................................... 143
6.4.2 APPS............................................................................ 144
6.4.3 KEY PLAYERS ............................................................... 144
6.5 FITNESS & LIFESTYLE THERAPEUTICS....................................144
6.5.1 DEVICES ...................................................................... 147
6.5.2 APPS............................................................................ 147
6.5.3 KEY PLAYERS ............................................................... 147
6.6 OTHERS .................................................................................. 148
7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE........150
7.1 INTRODUCTION ......................................................................150
7.1.1 MONITORING APPLICATIONS ...................................... 152
7.1.1.1 Key Participants ...................................................... 157
7.1.2 DIAGNOSIS & TREATMENT ........................................... 157
7.1.3 EDUCATION AND AWARENESS ..................................... 164
7.1.4 HEALTHCARE MANAGEMENT......................................... 169
7.1.5 WELLNESS & PREVENTION........................................... 174
7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS
MARKET ....................................................................... 178
7.1.7 REMOTE DATA COLLECTION ......................................... 181

7.1.7.1 Key Market Developments ........................................182
8 GLOBAL MHEALTH MARKET–GEOGRAPHY ..............................................184
8.1 INTRODUCTION ......................................................................184
8.1.1 MARKET STATISTICS.................................................... 185
8.1.2 THE AMERICAS............................................................. 186
8.1.3 NORTH AMERICA.......................................................... 189
8.1.3.1 The U.S..................................................................189
8.1.3.1.1 Key Market trends, Developments and
Participants ................................................... 190
8.1.3.1.1.1 Key Market Trends and Developments............... 190
8.1.3.2 Canada ..................................................................191
8.1.3.2.1 Key Market Trend...........................................192
8.1.3.2.2 Key players ................................................... 192
8.1.3.3 South America ........................................................ 192
8.1.3.3.1 Constraints ................................................... 192
Participants ................................................... 193
8.1.4 ASIA-PACIFIC (APAC).................................................. 194
8.1.4.1 Key Drivers in APAC................................................. 197
Participants ................................................... 198
8.1.4.1.1.1 Market Trends & Development.......................... 198
8.1.4.2 CHINA ...................................................................200
8.1.4.3 JAPAN....................................................................200
8.1.4.4 AUSTRALIA............................................................. 201
8.1.4.5 INDIA ....................................................................201
8.1.5 EUROPE ....................................................................... 202
8.1.5.2 The U.K. ................................................................ 206
8.1.5.3 Germany................................................................ 206

8.1.6 REST OF THE WORLD (ROW) ........................................ 207
8.1.6.1 Africa.....................................................................210
Participants ................................................... 210
8.1.7 MIDDLE EAST............................................................... 211
8.1.7.1 Key Market Trends, Developments and Participants......211
9 KEY MARKET DEVELOPMENT AND STRATEGIES....................................213
9.1 INTRODUCTION ......................................................................213
9.1.1 PARTNERSHIPS, AGREEMENTS, AND
COLLABORATIONS ....................................................... 214
9.1.2 MERGERS & ACQUISITIONS ......................................... 216
9.1.3 PRODUCT DEVELOPMENT AND LAUNCH ........................ 217
9.1.4 BUSINESS EXPANSION/CONTRACTS ............................ 219
9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS .............. 221
9.1.6 OTHERS (EVENTS & RECOGNITIONS) ........................... 222
10 COMPANY PROFILES.........................................................................................224
1.1 AGAMATRIX, INC. ...................................................................224
10.1.1 OVERVIEW................................................................... 224
10.1.2 FINANCIALS................................................................. 224
10.1.3 KEY DEVELOPMENTS .................................................... 225
10.2 ALIVECOR, INC. ......................................................................226
10.2.1 OVERVIEW................................................................... 226
10.2.2 FINANCIALS................................................................. 226
10.3 APPLE, INC. ............................................................................230
10.3.1 OVERVIEW................................................................... 230
10.3.2 FINANCIALS................................................................. 231
10.3.2.1 Overall Financials .................................................... 231
10.3.2.2 Financials By Segment .............................................232
10.3.2.3 Financials By Region ................................................ 233

10.3.2.4 Financial Summary .................................................. 233
10.3.3 KEY DEVELOPMENT ...................................................... 234
10.4 ATHENAHEALTH INC. .............................................................. 235
10.4.1 OVERVIEW................................................................... 235
10.4.2 FINANCIALS................................................................. 236
10.4.2.2 Financial by Segments .............................................237
10.4.3 KEY DEVELOPMENT ...................................................... 238
10.5 AT&T, INC............................................................................... 240
10.5.1 OVERVIEW................................................................... 240
10.5.2 FINANCIALS................................................................. 241
10.6 BIOTELEMETRY, INC. (CARDIONET) .......................................244
10.6.1 OVERVIEW................................................................... 244
10.6.2 FINANCIALS................................................................. 245
10.6.2.2 Financials by Segment .............................................246
10.7 GE HEALTHCARE .....................................................................248
10.7.1 OVERVIEW................................................................... 248
10.7.2 FINANCIALS................................................................. 249
10.8 GOOGLE INC. ..........................................................................253
10.8.1 OVERVIEW................................................................... 253
10.8.2 FINANCIALS................................................................. 254

10.9 JAWBONE, INC........................................................................256
10.9.1 OVERVIEW................................................................... 256
10.9.2 FINANCIALS................................................................. 256
10.10 JOHNSON & JOHNSON ............................................................ 258
10.10.1 OVERVIEW................................................................... 258
10.10.2 FINANCIALS................................................................. 259
10.10.2.2 Net Revenue By Segment .........................................259
10.10.2.3 Net revenue by Region.............................................260
10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS ...........261
10.11.1 OVERVIEW................................................................... 261
10.11.2 FINANCIALS................................................................. 262
10.12 MEDTRONIC PLC .....................................................................265
10.12.1 OVERVIEW................................................................... 265
10.12.2 FINANCIALS................................................................. 266
10.13 NIKE INC. ............................................................................... 269
10.13.1 OVERVIEW................................................................... 269
10.13.2 FINANCIALS................................................................. 270
10.13.2.2 Financials by Segments ............................................271
10.14 PFIZER.................................................................................... 272
10.14.1 OVERVIEW................................................................... 272
10.14.2 FINANCIALS................................................................. 273

10.14.2.4 FINANCIAL SUMMARY ..............................................275
10.15 PHILIPS HEALTHCARE ............................................................ 276
10.15.1 OVERVIEW................................................................... 276
10.15.2 FINANCIALS................................................................. 277
10.16 QUALCOMM, INC. ....................................................................279
10.16.1 OVERVIEW................................................................... 279
10.16.2 FINANCIALS................................................................. 280
10.17 QUEST DIAGNOSTICS INC. ..................................................... 284
10.17.1 OVERVIEW................................................................... 284
10.17.2 FINANCIALS................................................................. 285
10.18 ROCHE HOLDING AG-BR ......................................................... 288
10.18.1 OVERVIEW................................................................... 288
10.18.2 FINANCIALS................................................................. 289
10.19 SAMSUNG ELECTRONICS CO. LTD. ..........................................291

10.19.1 OVERVIEW................................................................... 291
10.19.2 FINANCIALS................................................................. 293
10.19.2.1 Overall financials..................................................... 293
10.20 SANOFI PHARMA ....................................................................294
10.20.1 OVERVIEW................................................................... 294
10.20.2 FINANCIALS................................................................. 295
10.20.3 FINANCIALS BY SEGMENT............................................ 296
10.20.4 FINANCIAL SUMMARY.................................................. 296
10.21 WITHINGS SAS .......................................................................298
10.21.1 OVERVIEW................................................................... 298
10.21.2 FINANCIALS................................................................. 299

LIST OF TABLES
TABLE 1 LEADING COMPANIES IN THE MHEALTH MARKET 30
TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015) 47
TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS 51
TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM 57
TABLE 5 CONSORTIUMS IN MHEALTH MARKET 59
TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET 60
TABLE 7 REGULATORY BODIES IN MHEALTH MARKET 63
TABLE 8 MHEALTH MARKET CERTIFICATIONS 67
TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER 71
TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER 72
TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE 73
TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT 73
TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION 74
TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION) 76
TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-
2022 ($MILLION) 79
TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE
2014-2022 ($MILLION) 81
TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-
2022 ($MILLION) 108
TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE
2014-2022 ($MILLION) 109
TABLE 19 KEY DEVELOPMENTS 115
TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS 119
TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT 122
TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION) 125
TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY
APPLICATION, 2014-2022 ($MILLION) 126
TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY
GEOGRAPHY, 2014-2022 ($MILLION) 127
TABLE 25 TYPE OF APP 129
TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-
2022 ($MILLION) 133

TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-
2022 ($MILLION) 134
TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY
TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY
TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY
TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY
TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY
TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY,
2014-2022 ($MILLION) 149
TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022
($MILLION) 151
TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY
ECOSYSTEM, 2014-2022 ($MILLION) 152
THERAPEUTICS, 2014-2022 ($MILLION) 153
TABLE 42 REMOTE MONITORING IN GEOGRAPHIES 156
TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES 162
TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES 167

TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES 173
TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT
GEOGRAPHIES 177
TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY
TABLE 62 MHEALTH: KEY DEVELOPMENTS (2011- 2015) 182
TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION) 185
TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022
($MILLION) 186
TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-
2022 ($MILLION) 187
TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2014-
2022 ($MILLION) 188
TABLE 67 THE U.S.: KEY DEVELOPMENTS 191
TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2011-2015) 193
TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION) 194
TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022
($MILLION) 195
TABLE 71 KEY DEVELOPMENTS IN APAC 198
TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION) 202
TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022
($MILLION) 203
TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT 205

TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION) 207
TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION) 208
TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022
($MILLION) 209
TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS(2011-2014) 210
TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2014-2011) 212

LIST OF FIGURES
FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA 21
FIGURE 2 BIS RESEARCH METHODOLOGY 23
FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL
MARKET 24
FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY 26
FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION) 32
FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION) 33
FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION) 34
FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION) 35
FIGURE 9 MARKET DRIVERS AND CHALLENGES 37
FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS 38
FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS 39
FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS 42
FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS 45
FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS 49
FIGURE 15 VALUE CHAIN 54
FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS 58
FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES 66
FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS 70
FIGURE 19 MHEALTH ECOSYSTEM 77
FIGURE 20 TYPE OF MHEALTH DEVICES 79
FIGURE 21 SMBD DEVICE USES 83
FIGURE 22 USES OF BP MONITORING DEVICE 86
FIGURE 23 PULSE OXIMETER USES 87
FIGURE 24 WEARABLE DEVICE COMPONENTS 90
FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES 90
FIGURE 26 HAND WORN MHEALTH DEVICES 91
FIGURE 27 APPLE WATCH FIGURE 92
FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS 93
FIGURE 29 GOOGLE’S CONTACT LENS 94
FIGURE 30 HEAD WORN DEVICES 94
FIGURE 31 ELECTRONIC FINGERTIP 96
FIGURE 32 COMPONENTS OF BIOSTAMP 98

FIGURE 33 MYO ARMBAND BY THALMIC LABS 99
FIGURE 34 NON-CLINICAL BENEFITS 100
FIGURE 35 WEARABLE MEDICAL DEVICES 101
FIGURE 36 FITNESS TRACKING DEVICES 103
FIGURE 37 TYPES OF MHEALTH SERVICES 107
FIGURE 38 TYPES OF APPS 111
FIGURE 39 BENEFITS OF BIG DATA 114
FIGURE 40 BENEFITS OF NETWORK & SERVICES 117
FIGURE 41 ROLES OF MOBILE OPERATORS 118
FIGURE 42 ROLE OF HEALTHCARE PROVIDERS 121
FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS 124
FIGURE 44 BENEFITS OF MHEALTH IN CVDS 128
FIGURE 45 BENEFITS OF MHEALTH 135
FIGURE 49 TYPES OF MHEALTH APPLICATION 150
FIGURE 50 ADVANTAGES OF REMOTE MONITORING 155
FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES 161
FIGURE 52 EDUCATION & AWARENESS SERVICES 167
FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT 169
FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY 184
FIGURE 55 APAC: MARKET DRIVERS 197
FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
(2015) 214
FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS(2015) 216
FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2015) 218
FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2015) 220
FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS( 2015) 222
FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2012-2014 231
FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2012-2014 232
FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2012-2014 233
FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION) 236
FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION) 237
FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2012-2014 241
FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2012-2014 242
FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2012-2014 245

FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2012-
2014 246
FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2012-2014 249
FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014 250
FIGURE 72 GE HEALTHCARE SEGMENT, 2014 250
FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2012 - 2014 ($BILLION) 254
FIGURE 74 J&J: OVERALL FINANCIALS, 2012 - 2014 ($ BILLION) 259
FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2012-2014 262
FIGURE 76 NET REVENUE BY SEGMENTS, 2012-2014 263
FIGURE 77 NIKE: OVERALL FINANCIALS 2012 - 2014 ($BILLION) 270
FIGURE 78 NIKE: REVENUE BY REGION (2012-2013) 271
FIGURE 79 PFIZER: OVERALL FINANCIALS, 2012-2014 ($BILLION) 273
FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION) 274
FIGURE 81 PFIZER: FINANCIALS BY REGION, 2012-2013 ($BILLION) 274
FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2012-2014 ($MILLION) 277
FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2012-2014 ($MILLION) 278
FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION) 278
FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2012-2014 ($BILLION) 280
FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION) 281
FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2012-2014 ($MILLION) 281
FIGURE 88 QUEST: OVERALL FINANCIALS, 2012-2014 ($MILLION) 285
FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2013-2014 ($MILLION) 286
FIGURE 90 ROCHE: OVERALL FINANCIALS, 2012-2014 ($BILLION) 289
FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2012-2014 ($BILLION) 290
FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION),
2012-2014 293
FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2012-2014 295
FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2012-2014 296

LIST OF ACRONYMS
Acronyms Descriptions
ABC About Building Connections
APAC Asia-Pacific
APIs Application Program Interfaces
ATA American Telemedicine Association
BGM Blood Glucose Monitoring
BIDMC Beth Israel Deaconess Medical Center
BP Blood Pressure
CHF Congestive Heart Failure
CIA Central Intelligence Agency
CIHR Canadian Institutes of Health Research
EBRD European Bank for Reconstruction and Development
ECG Electrocardiogram
e-health electronic health
EHR Electronic Health Records
FCC Federal communications commission
FDA Food and Drug Administration
FDA Food and Drug Administration
GDP Gross Domestic Product
GHTF Global Harmonization Task Force on Medical Devices
GMTA Global Medical Technology Alliance
GSMA Groupe Speciale Mobile Association

HIPAA Health Insurance Portability and Accountability Act
HIPAA Health Insurance Portability and Accountability Act
HMD Head Mounted Display
HUD Head Up Display
ICT Information and communications technology
ITU International Telecommunication Union
IVR Interactive Voice Response
LMICs Low- And Middle-Income Countries
MMA Medical Mobile Application
MRS Medical Record System
ODK Open Data Kit
OECD Organization for Economic Co-Operation and Development
OEM original equipment manufacturers
OTC Over-The-Counter
PCORI Patient-Centered Outcomes Research Institute
PDAs personal digital assistant
PESTLE Political, Economical, Social, Technological and Economical
PLGM Predictive Low Glucose Management
PPP purchasing power parity
ROW Rest Of The World
U.K. United Kingdom
U.S.A. United States of America
UCSF University of California at San Francisco
USAID United States Agency for International Development

WHO World Health Organization
WHUSA Women Health USA
WLSA Wireless-Life Science Alliance’s
WLSA Wireless-Life Sciences Alliance

1 REPORT SCOPE
1.1 SCOPE OF THE STUDY
The scope of this report is limited to the a detailed study of the Mobile Health (mHealth)
devices and services in the market. The study includes an analysis of therapeutics and
applicationsin which mHealth is used, in addition to the market study of the mHealth devices
and services used across different geographical regions. The study presents a detailed analysis
of the mHealth ecosystem (devices and services), therapeutics, applications, and geography
along these lines: market size, drivers, growth opportunities, and challenges. The major end-
use application areas of mHealth devices and services with respect to the market size and
growth rate has also been identified and discussed in the report.
1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE
The figure below shows the list of market coverage features which are incorporated in this
research study.
FIGURE 1
MHEALTH MARKET STUDY: COVERAGE AREA
Global mHealth Market Coverage
Ecosystem Therapeutics Type Application Type
mHealth Devices
mHealth Services
Cardiovascular
Respiratory
Diabetes
Neurology/Mental Health
Fitness & Lifestyle
Remote Monitoring
Diagnosis and Treatment
Others
Education and Awareness
Healthcare Management
Prevention & Wellness
Geography
The Americas
Europe
APAC
Rest of the World (RoW)
Source: BIS Research Analysis

1.1.2 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH
METHODOLOGY
The following illustrative figure shows the market research methodology applied in preparing
this report on the mHealth market.
FIGURE 2
MHEALTH MARKET: RESEARCH METHODOLOGY
Secondary
Research
 Value Chain
 Key Players
 End-user Applications
 Market Classification
 Annual Reports of Key Industry Players
 Geographical Markets with their Market Shares
 Market Trends
 Technological Developments
Primary Research
 Numbers Validation
 Competitive Landscape Validation
 Market Dynamics Validation
Market Crackdown
 Top-Down Approach
 Bottom-Up Approach
 Data Triangulation
 Qualitative & Quantitative Analysis
 Market Segmentation
 Market Estimates
 Market Forecasts
1.1.3 REPORT DESCRIPTION
The dynamic nature of the regulatory compliances in the healthcare industry and the reduced
risk factors are pushing the acceptance of mHealth solutions across varied end-user segments.

As a disease’s diagnosis, treatment, monitoring and other services can be managed remotely
around the world; mHealth market is gaining traction and is expected to grow at a double digit
CAGR through 2015 to 2022
The growing popularity of wearable devices pertaining to medical applications is further
propelling the demand of mHealth solutions across the ecosystem. In Mobile Health (mHealth)
services, mobile communications such as personal digital assistant (PDAs), laptops, and mobile
phones among others, are used for providing health information and services. mHealth enables
various electronic health (e-health) data content and services to users, by using wireless
technologies such as WiMax, Bluetooth, GSM/GPRS/3G, and WiFi among others. These data
contents and services are accessed by the health providers, consumers (patients) and other
related users through devices such as mobile phones, smart phones, PDAs, laptops and tablet
PCs (personal computers).
The mHealth market report presents detailed analysis of the entire mHealth ecosystem and
provides extensive insights of the different mHealth devices and services providers. The report
also focuses on different applications in which mHealth solutions are being used. Further, the
scope of the report includes the therapeutics of different disease types managed by mHealth
devices and services. All of the above mentioned report coverage parametersarediscussed
across different regions like The Americas, Europe, Asia Pacific (APAC) and Rest of the World
(RoW).
While highlighting the key driving and restraining forces for this dynamic market, the report
also provides a comprehensive section of the prominent consortiums, compliance, and
regulatory bodies and their involvement in the mobile health (mHealth) market.
The answers to the following key questions can be found in the report:
What are the major market drivers, challenges and opportunities of the mHealth
market and their use cases?
Which factors will be driving the market through the forecast period?
What factors are currently challenging the mHealth industry?
What are the use cases and key platforms to deliver the services of each application?

What are the key developmental strategies in different applications across all
regions?
How will the key market players leverage on key developments such as Mergers and
Acquisitions, Partnerships, and Product Launch among others?
Which compliances and certifications are necessary to make a product acceptable?
Which geographical region will lead the global mHealth market by the end of the
forecast period?
Who are the key players in the mHealth market?
The research tries to answer various aspects of the mHealth market such as factors driving the
market, its threats that can possibly slow down the market growth and the current growth
opportunities that are going to shape the market expansion of mHealth solutions (devices and
services). The research incorporates Porter’s Five Force Model for in-depth analysis of the
mHealth device market and an assessment of the factors governing it. The report builds itself
upon a comprehensive value chain giving a clear understanding of ecosystem of mHealth
market penetration.
Our study includes an overview and analysis of the mHealth market by ecosystem,
applications, therapeutics and geographical regions, allowing the research to develop a
comprehensive outlook of the market. The report includes the profiles of major players in the
mHealth ecosystem that allows its reader to get an insight into the industry trends.
Towards the end of the report, readers will have a clear understanding of the market
dynamics, its major drivers and the underlying threats and challenges of the global mHealth
market.
Some of the leading companies in the mHealth market are listed below:-
TABLE 1
LEADING COMPANIES IN THE MHEALTH MARKET

S.No. Company Name
1 AgAmatrix, Inc.
2 AliveCor, Inc.
3 APPLE, Inc.
4 AT&T, Inc.
5 AthenaHealth Inc.
6 BioTelemetry, Inc. (Cardionet)
7 GE Healthcare
8 Google inc.
9 Jawbone, Inc.
10 Johnson & Johnson
11 Laboratory Corporation Of America Holdings
12 Medtronic PLC
13 NIKE INC.
14 Pfizer
15 Philips Healthcare
16 Qualcomm, Inc.
17 Quest Diagnostics Inc
18 Roche Holding AG-Br
19 Samsung electronics Co. LTD.
20 Sanofi
21 WITHINGS SAS

2 EXECUTIVE SUMMARY
Mobile Health refers to using mobile communications, such as personal digital assistant
(PDAs), laptops, and mobile phones for health services and related information.
On the basis of ecosystem, the global mHealth market is classified into devices and services.
Device segment includes medical devices, health & fitness devices and home care devices
among others. Moreover, the service segment is further fragmented into mobile apps &
content solution developers, network/Mobile operators and healthcare & pharmaceuticals.
FIGURE 3
GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)
XX
XX
XX
XX
XX
XX
XX
2014 2015 2016 2017 2018 2019 2020 2021 2022
$Million
mHealth devices mHealth Services
Source: ME-BIS Research
The mHealth services dominated the market in 2014 and is expected to grow over $XX billion
by the end of the forecast period due to the increasing usage of mHealth solutions by
healthcare providers and pharmaceutical companies along with end users (patients). In
addition to this, different service providers are entering into partnerships with other ecosystem
players to enhance the development of mHealth solutions. However, device segment is

expected to grow in near future with a high CAGR of XX%, from 2015 to 2022, due to
increasing integration of mHealth devices with smart phones and weareables, and also,
increasing opportunities of connected health solutions are predicted to promote the growth of
this market through the forecast period.
The global mHealth market on the basis of therapeutics is classified as cardiovascular,
diabetes, respiratory, neurology/mental health, fitness & lifestyle and other diseases. At
present, diabetes is dominating in the market and is expected to reach $XX billion by 2022, as
the number of diabetic patients are increasing every year and thus, deployment of monitoring
and diagnosis applications of diabetes is also anticipated to increase tremendously. A large
number of diabetes apps have been developed in the recent years that provide information,
diet charts, blood glucose level data, and education among other services. Regardless of this
fact, the cardiovascular therapeutic segment is estimated to grow at CAGR of XX% from 2015
to 2022.
FIGURE 4
GLOBAL MHEALTH MARKET, BY THERAPEUTICS,
2014-2022 ($MILLION)
XX
XX
XX
XX
XX
XX
2014 2015 2016 2017 2018 2019 2020 2021 2022
Cardiovascular Diabetes Respiratory Neurology/ Mental Health Fitness & Lifestyle Others
The primarily reason attributed to the growth of the mHealth therapeutics market is due to the
increasein cardiac diseases, hypertension, high/low blood pressures, and other heart related

issues. The patients are more concerned about this these diseases as theycan be effectively
controlled at its primary stages and help them in emergency cases.
The global mhealth market, on the basis of these applications, is segmented into: monitoring,
diagnosis & treatment, education & awareness, healthcare management, prevention &
wellness and others. The monitoring application is acquiring a major share of the market and is
expected to grow over $XX billion by the end of forecast period.
FIGURE 5
GLOBAL MHEALTH MARKET, BY APPLICATION,
2014-2022 ($MILLION)
XX
XX
XX
XX
XX
XX
XX
2014 2015 2016 2017 2018 2019 2020 2021 2022
Monitoring Applications Diagnosis & Treatment Education & Awareness
Healthcare Management Wellness & Prevention Others
Most of the applications are deployed in monitoring of patients, post-acute care, maternal
health, and communicable diseases among others. However, education & awareness
application is foreseen to have high potential growth by the end of 2022 and is predicted to
grow at a CAGR of XX% during the forecast period. The increase in this application is due to
the growing involvement and concern of people regarding their personal health and it also

includes an increase in telecommunication and wireless technologies that enables users to
grasp information easily.
The Americas has been the largest contributor to the net revenue in the global mHealth market
and is expected to grow over $XX billion by 2022. One of the main reasons for this dominance
is the advancement of internet and communication technologies in the developed countries of
America in comparison to other regions.
FIGURE 6
GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
XX
XX
XX
XX
XX
XX
2014 2015 2016 2017 2018 2019 2020 2021 2022
The Americas Europe Asia-Pacific (APAC) RoW
However, the Rest Of the World (ROW) that majorly includes the African region and some
parts of the Middle Eastern region is poised to grow at the highest CAGR of XX% from 2015 to
2022. This is due to the increasing adoption of mHealth solutions because of aspects such as
low costs and the sheer convenience; and also because of availability of lesser number of
healthcare workers and practitioners over a large number of population.

3 MARKET OVERVIEW
3.1 INTRODUCTION
Mobile health (mHealth) is one of the most modernized trends in the healthcare industry, that
has shown tremendous progress in the last few years. This trend is observed due to the
flourishing growth of personal health devices, which can be easily worn or used with a
smartphone or tablet. Mobile Health refers to the use of mobile communications, such as
personal digital assistant (PDAs), laptops, and mobile phones among others, for health
services and information. mHealth is a process of enabling various e-health data content and
services to users, by using wireless technologies such as WiMax, Bluetooth, GSM/GPRS/3G,
and WiFi among others. These data contents and services are accessed by the health
providers, consumers (patients), and other related users through devices such as mobile
phones, smart phones, PDAs, laptops, and tablet PCs (personal computers).
3.2 MARKET DYNAMICS
The global mHealth market has been identified as one of the fastest growing industries, owing
to the changing dynamics of the legal and regulatory framework and the intense competitive
rivalry among a plethora of public companies.

FIGURE 7
MARKET DRIVERS AND CHALLENGES
 Literacy and language barriers in low and middle-income
countries (LMICs)
 Invasion of Privacy
 Potential risk of Hardware or Software failure
 StringentRegulations and Standards
 Lack of Awareness aboutthe possible applications of
mHealth
CHALLENGES
 Patients Involvementin personal healthcare
 Penetration of smartphones and wearable devices into
healthcare
 Integration of wireless technologies with portable
healthcare devices
 Benefits of Costeffectiveness and Patients’ Convenience
 Increase in Lifestyle Disease
DRIVERS
The following segment will discuss the key market driving and restraining / challenging forces,
including the impact analysis for the same. Also, the opportunities have been identified and
discussed which can be used to the market player’s advantage to uplift their market position in
the growing industry.
3.2.1 MARKET DRIVERS
Market drivers are defined as the forces and trends that enable the markets to develop and
grow.The most common market drivers in the mHealth market are: patient’s involvement in
personal healthcare, penetration of smartphones and wearable devices into healthcare
industry, integration of wireless technologies with portable healthcare devices, benefits of Cost
effectiveness and Patients’ convenience and Increase in lifestyle diseases.

FIGURE 8
MHEALTH MARKET DRIVERS: IMPACT ANALYSIS
DRIVERS IMPACT
1 Involvementof patients into personal healthcare
2 Introduction of smartphones and wearable devices into healthcare
3 Integration of wireless technologies with portable healthcare devices
4 Benefits of Costeffectiveness and Patients’ Convenience
5 Increase in Lifestyle Disease
Low Mediocre Medium High Very High

3.2.2 MARKET CHALLENGES
Market challenges are the factors which are slowing down the growth of the market. These
factors challenge the market players from meeting the industry requirements and perform
ideally.
FIGURE 9
MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS
CHALLENGES/ RESTRAINTS IMPACT
1 Lowliteracy and language barriersin low- and middle-income countries(LMICs)
2 Invasion of Privacy
3 Potential risk of Hardware or Software failure
4 Stringent Regulations and Standards
5 Lack of Awarenessabout the possible applications of m-Health
Low Mediocre Medium High Very High

4 INDUSTRY DYNAMICS
4.1 VALUE CHAIN OF THE MHEALTH MARKET
The value chain analysis of the global mHealth market includes various stakeholders such as
device manufacturers, content providers, software developers, app developers, network
providers, and healthcare workers. They all are working in collaboration with one another to
achieve common goals i.e. providing customized services to patients for better standards of
wellness and fitness. The overall value chain of mHealth market is regulated by government
compliances and standards which are essential for this industry as it is directly related to
human beings health and fitness.
FIGURE 10
VALUE CHAIN

TABLE 2
VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM
Ecosystem players Key Players
Device Manufacturers
Alive cor, Agamatrix, Fitbit, Withings, GE Healthcare,
Jawbone, and Medtronic among others
App Developer
Samsung, Apple, IBM, Google Inc., iBigStar,
andAthenaHealth among others
Network / Mobile Operators AT&T, T-mobile, Vodafone, China Mobile
Healthcare provider &
Pharmaceuticals
Roche, Abbott, Quest Diagnostics, Pfizer, Bayer and GSK
among others

FIGURE 11
MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS
MEDIUM TO HIGH
Degree of Competition
MEDIUM
Threat from Substitutes
MEDIUM
Buyer's Power
MEDIUM
Supplier 's Power
LOW TO MEDIUM
Threat from New
Entrants
4.1.1 BARGAINING POWER OF BUYER
The bargaining power of the buyer is considered to have a “medium” impact on the industry.
The factors affecting the industry are discussed in the table below:-

TABLE 3
FACTORS IMPACTING THE BUYER’S BARGAINING POWER
Factors Impact
Industry concentration Medium
Threat of backward integration Low
Buyer information about supplier product Medium
Switching cost Medium
Present of substitutes High
The bargaining power of the buyers assesses how easy it is for the buyers to have an effect on
the prices of the mHealth solutions. The power of buyers is the impact that customers have on
a producing industry. The bargaining power of the buyer is medium as the industry
concentration is also levelled at medium, butthe threat of backward integration is
low.However, the buyer’s information about supplier product is medium, the switching cost is
medium,whereas the present of substitutes is high.
4.1.2 BARGAINING POWER OF SUPPLIER
The industry impact of the supplier’s Bargaining Power is considered to have a “medium” level
impact.

5 GLOBAL MHEALTH MARKET ECOSYSTEM
5.1 INTRODUCTION
The complexities of the mHealth ecosystem is due to a wide variety of stakeholders and
players in the global mHealth market. This ecosystem includes component providers of original
equipment (sensors, mobile phones, and Personal Digital Assistant (PDAs), medical device
manufacturers, healthcare providers, pharmaceutical companies, content developers, and
mobile operators. The global mHealth market accounted for $XX billion in 2014, dominated by
the mobile operator segment. This estimate does not include the expenditure on smartphones,
tablets and other ordinary mobile phones.
TABLE 4
GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM,
2014-2022 ($MILLION)
Ecosystem 2014 2015 2017 2019 2021 2022
CAGR%
(2015-
2022)
mHealth
devices
XX XX XX XX XX XX XX
mHealth
Services
Total XX XX XX XX XX XX XX

6 GLOBAL MHEALTHMARKET – THERAPEUTICS
6.1 INTRODUCTION
The mHealth solutions are effectively involved in curing many chronic and lifestyle diseases
such as diabetes, sleep apnea, obesity, hypertension and cardiac diseases among others. With
developments and innovations in wireless and mobile communication technology, m-Health is
considered to be the most efficient and effective way for both patients and healthcare workers.
These solutions are helping patients to personalize their healthcare options and also facilitating
physicians and clinicians to monitor the physiological factors in real time and accordingly
provide feedback to the patients.
FIGURE 12
MHEALTH: MARKET BY THERAPEUTICS
Global mHealth Therapeutics
Market
Cardiovascular
Diabetes
Respiratory
Neurology/ Mental Health
The subsequent sections the devices, applications, key developments, use cases and key
players of each therapeutic type. It also mentions the benefits of mHealth in each section when
and wherever required.

6.1.1 GLOBAL MARKET STATISTICS
TABLE 5
GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS,
2014-2022 ($MILLION)
Disease
Type
2014 2015 2017 2019 2021 2022
CAGR%
(2015-
2022)
Cardiovascular XX XX XX XX XX XX XX
Diabetes XX XX XX XX XX XX XX
Respiratory XX XX XX XX XX XX XX
Neurology/
Mental Health
Fitness &
Lifestyle
Others XX XX XX XX XX XX XX
The global mHealth market for therapeutics accounted for $XX billion in 2014 and is expected
to grow to $XX billion by 2022, at an estimated CAGR of XX% from 2015 to 2022. The
diabetes segment dominated the global market in 2014 and accounted for $XX billion. The
major reasons include development of more diagnosis and monitoring devices that are
portable and technologically advanced . However, cardiovascular will be the fastest growing
therapeutic segment followed by respiratory and will be growing at a CAGR of XX% and XX%
respectively from 2015 to 2022.

7 GLOBAL MHEALTHMARKET – APPLICATION/
SOLUTION TYPE
7.1 INTRODUCTION
The global mHealth market is further classified on the basis of applications for which the
mHealth solutions are being deployed. Large numbers of developing countries are using
mHealth solutions to address healthcare and fitness related problems. With the rapid increase
of smartphones and communication technologies in these regions, global mHealth applications
have been able to solve critical problems which arose due to poor infrastructure and
insufficient number of health-workers. Moreover, increasing demand for monitoring and
wellness applications including activity tracking, continuous glucose monitoring, heart rate
monitoring, and non-invasive drug delivery has surged forward the development of more
innovative products by big market players.
The global mHealth market is very dynamic and shows a wide range of applications that are
constantly escalating with the introduction of integrated smart devices. Applications of the
mHealth market are classified into the segments mentioned in the figure below:
FIGURE 13
TYPES OF MHEALTH APPLICATION
mHealth
Application
Market
Monitoring
Applications
Education
And
Awareness
Education
And
Awareness
Healthcare
Management
Wellness &
Prevention
Others
Application

The global mHealth market has been segmented into six parts that includes: monitoring,
diagnosis and treatment, education and awareness, healthcare management, prevention and
wellness and others.
TABLE 6
GLOBAL MHEALTH MARKET VALUE, BY APPLICATION,
2014-2022 ($MILLION)
Application
Type
2014 2015 2017 2019 2021 2022
CAGR%
(2015-
2022)
Monitoring
Applications
Diagnosis &
Treatment
Education &
Awareness
Healthcare
Management
Wellness &
Prevention
Others XX XX XX XX XX XX XX
The global mHealth market for application accounted for over $XX billion in 2014 and is
expected to grow at a CAGR of XX% from 2015 to 2022. Monitoring application of mHealth
dominated the global market in 2014 and accounted for $XX and it is due to increasing
deployment of mHealth solutions by healthcare providers and workers. This application helps
them to monitor the patient’s health and activity by using medical or weareable devices that
are connected with mHe

8 GLOBAL MHEALTH MARKET–GEOGRAPHY
8.1 INTRODUCTION
The global mHealth market is segmented into four different regions namely; The Americas,
Europe, Asia-Pacific (APAC), and Rest of the World (ROW). We can also classify regions on the
basis of economic development that includes: untapped markets, emerging markets,
developing markets, and the developed markets. However, on the basis of opinion from
industry experts and various thought leaders, the report has been segmented into four
geographical regions which are as follows:
FIGURE 14
GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY
In the diagram, “The Americas” is a phrase technically used, but when you use the two
continents, its North AMERICA and South AMERICA. Not Americas.
This chapter further includes the key developments, market trends, and the market &
industrial dynamic factors of each region. This chapter also includes description of regulations
and compliances that are most important for mHealth market and also highlights key
participants of each region.

8.1.1 MARKET STATISTICS
TABLE 7
GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY,
2014-2022 ($MILLION)
Region 2014 2015 2017 2019 2021 2022
CAGR%
(2015-
2022)
The
Americas
Europe XX XX XX XX XX XX XX
Asia-
Pacific
(APAC)
RoW XX XX XX XX XX XX XX
The global mHealth market by geography accounted for over $XX billion in 2014 and is
expected to grow over$$XX billion by 2022. The Americas dominated the global market in
2014 with a share of $XX billion due to increasing adoption of mobile health solutions for
prevention and wellness. Following the Americas is APAC, where large number of
developments in mHealth have been noticed in the last few years. However, in ROW
specifically Africa is estimated to show highest growth with a CAGR of XX% from 2015 to
2022.

9 COMPANY PROFILES
9.1 ATHENAHEALTH INC.
9.1.1 OVERVIEW
Particular Specifications (as of 2015)
Website www.athenahealth.com
Contact Details
311 Arsenal Street
Watertown, MA 02472
United States
Tel:617-402-1000
Fax: 617-402-1099
Year of Establishment 1997
Ownership Type Public
Company Type Service Provider
Number of Employees 3, 676
Subsidiaries
Epocrates Inc., Anodyne Health Partners, Inc., athena Point
Lookout, LLC, athenahealth MA, Inc., athenahealth Security
Corporation, athenahealth Technology Private Limited, and
Proxsys LLC among others
Competitors
GE Healthcare Ltd ., Allscripts Healthcare Solutions, Inc.,
ADP AdvancedMD Software, Inc., Epic Systems
Corporation, CareCloud Corporation, NextGen Healthcare
Information Systems, LLC, OptumInsight, Inc., Practice
Fusion, Inc., and SCI Solutions, Inc.
Related Product &Services
Electronic health records, revenue cycle management,
medical billing, patient engagement, care coordination, and
population health management
Source: AthenaHealth Website, BIS Research

9.1.2 FINANCIALS
9.1.2.1 Overall Financials
FIGURE 15
ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION)
2012 2013 2014
Net Revenue 422.3 595 752.6
Net Income 18.7 2.6 -3.1
OperatingIncome 29.5 11.00 1.00
-XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX
NetIncome&OperatingIncome
($Million)
NetRevenue
($Million)
Source: AthenaHealth Annual Report, BIS Research

9.1.2.2 Financial by Segments
FIGURE 16
ATHENAHEALTH: NET REVENUE, BY SEGMENT,
2012-2014 ($MILLION)
XX
XX
XX
XX
XX
XX
XX
XX
XX
Business services Implementation and other
2012
2013
2014
Source: Athena Health Annual Report, BIS Research
9.1.2.3 Financial Summary
The net revenue in 2014 was accounted to $XX million as compared to $XX million in 2013.
The sales have increased due to acquisition of Epocrates, Inc. which is recognized for
developing medical applications. These applications are used by health care providers to
diagnose and treat patients. The company operates through these two segments, mainly:
Business services and Implementation, among others.

9.1.3 KEY DEVELOPMENT
Date Strategy Description
May 2015 Collaboration
AthenaHealth and ReviveHealth, a leading integrated
marketing communications firm,released findings on the
state of payer performance and provider perception of
those payers
April 2015 Partnership
AthenaHealth, Inc., and CareWell Urgent Care (CareWell)
entered into partnershipfor the connectivity and network
insight through AthenaOne cloud-based suite
April 2015 Collaboration
AthenaHealth, Inc. and Trinity Health collaborated to work
together to advance clinical integration and people-
centered care in the health system's multi-state
ambulatory network
April 2015 Product Launch
AthenaHealth, Inc. launched the athenaText app for Apple
Watch to provide the 'Digital Doctor'With messaging tool
inclusive of communication, clinical intelligence, and care
coordination
February
2015
Collaboration
AthenaHealth, Inc., and Beth Israel Deaconess Medical
Center (BIDMC)entered into an agreement to collaborate
on the development of athenahealth's acute care service
offering that will support the needs of large hospitals and
health systems across the U.S., and AthenaHealth. Ithas
also purchased webOMR, the web-based clinical
applications and Electronic Health Record (EHR) platform
developed by BIDMC
January
2015
Partnership
AthenaHealth and FCS partnered in strategic pilot
agreement to streamline administrative work and enhance
performance and financial results
January
2015
Acquisition
AthenaHealth announced the acquisition of RazorInsights, a
leader in cloud-based EHR and financial solutions for rural,
critical access, and community hospitals
December Event AthenaHealth Inc., announced that it will participate in the

2014 33rd Annual J.P. Morgan Healthcare Conference
December
2014
Partnership
AthenaHealth Inc., and Women Health USA (WHUSA), a
leading provider of business and clinical management
services for physicians, entered into a strategic partnership
in which WHUSA has selected the athenaOne suite of
services to support its network of over 250 providers,
serving more than 300,000 patients in Connecticut
December
2014
Partnership
AthenaHealth Inc., and Granite healthcare Network(GHN)
entered into a partnership to deliver patient insight and
support value-based care and GHN has selected
athenahealth's cloud-based athenaCoordinator Enterprise
Population Manager to improve care quality and
coordination across GHN's growing network of risk-based
payment arrangements
September
2014
Business Expansion
AthenaHealth Inc., opened new offices in Georgia, San
Francisco, Atlanta, and California.
July 2014 Partnership
AthenaHealth Inc., and Arise Austin Medical Center(AAMC),
a physician-owned and operated hospital and its network of
outpatient facilities, entered into a partnership under which
AAMC has selected athenahealth's athenaCoordinator
Enterprise service to advance care coordination for its
more-than-100-physician network
June 2014 Recognition
Epocrates Inc., a subsidiary of AthenaHealth, announced
that for the fifth consecutive year, Epocrates leads the
digital health market in terms of medical reference
application reach on smartphones
May 2014 Partnership
AthenaHealth Inc., and Henry Schein Medical, the U.S.
Medical business ofthe world's largest provider of health
care products and services entered into a strategic
agreementto help physicians operate highly-efficient,
successful practices, as well as provide high-quality care
through the delivery and use of athenahealth's athenaOne
suite of EHR

May 2014 Partnership
AthenaHealth Inc., and Summit Health Management
(Summit), a provider of innovative management services
for (SMG) to complement existing cloud-based revenue
cycle management service success
April 2014 Partnership
AthenaHealth Inc., and Steward Health Care System
(Steward) entered into a partnership in which Steward has
selected athenaCoordinator Enterprise to enable care
coordination for its employed providers and their patients
Source: AthenaHealth Website, BIS Research Analysis

DISCLAIMER
BIS Research provides valuable market intelligence to an exclusive group of customers in
response to orders. The report is licensed for the customer's internal use only and is subject to
restrictions set henceforth. This document and its contents are confidential and may not be
further distributed, published or reproduced, in whole or in part, by any medium or in any form
for any purpose, without the express written consent of BIS Research. Customer will not
disclose the contents of the report, whether directly in any media or indirectly through
incorporation in a database, marketing list, report or otherwise, or use or permit the use of
Information to generate any statistical or other information that is or will be provided to third
parties; or voluntarily produce Information in legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such
information is available. Any recommendation contained in this report may not be suitable for
all investors or businesses. The market conclusions drawn are necessarily based upon a
number of estimates and assumptions that, while considered reasonable by BIS Research as of
the date of such statements, are inherently subject to market fluctuations and business,
economic and competitive uncertainties and contingencies
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 650 228 0182

Sample - Global mHealth (Mobile Health) Market

Recommended

Recommended

More Related Content

What's hot

What's hot (19)

Viewers also liked

Viewers also liked (20)

Similar to Sample - Global mHealth (Mobile Health) Market

Similar to Sample - Global mHealth (Mobile Health) Market (20)

Sample - Global mHealth (Mobile Health) Market